medigraphic.com
ISSN 1561-3119 (Electronic)

2017, Number S1

<< Back Next >>

Rev Cubana Pediatr 2017; 89 (S1)

Epidemiology of pneumococcal meningitis in Cuban children younger than 6 years

Dickinson MF, Rodríguez OM

Language: Spanish
References: 31
Page: 52-64
PDF size: 156.12 Kb.


ABSTRACT

Introduction: pneumococcal meningitis is a serious global threat for small children.
Objectives: to describe and to evaluate some epidemiological characteristics of pneumococcal meningitis in children aged less than 6 years, which offers a referent to show the subsequent changes and to evaluate the impact of potential interventions.
Methods: a retrospective observational study was conducted in 483 notified cases (1998-2005) based on the national surveillance of community-acquired bacterial meningitis. The incidence and fatality rates (age group and sex) were estimated together with the probably included cases of meningitis caused by unidentified agent. The association of disease and death with some risks was also determined.Results: the incidence rate of children younger than 6 years was 3.4/105 pop with yearly variations. The breast-fed infants showed the highest incidence of 9.8/105 pop, particularly at the second, fourth and sixth months of age. Males slightly predominated over the females. There was not significant association between the disease and the day care/pre-school centers just in 2003, 2011, 2012 and 2015. The fatality rate reached 24.2 % with higher figures in breast-fed infants (25.8 %). Delay in having medical consultation (24 hours or more) was not associated to death but the late admission to hospital showed association just in breast-fed infants (p< 0.05).
Conclusions: S. pneumoniae is the main lethal agent for bacterial meningitis at the community level in children aged less than 6 years, particularly in breast-fed ones. Although the actual number of cases may be higher than the reported one, the surveillance provides indispensable information for evaluation of impact of future interventions and subsequent changes.


REFERENCES

  1. Simell B, Auranen K, Käyhty H, Goldblatt D, Dagan R, O'Brien KL, et al. The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines. 2012;11:841-55.

  2. Abdullahi O, Karani A, Tigoi CC, Mugo D, Kungu S, Wanjiru E, et al. Rates of acquisition and clearance of pneumococcal serotypes in the nasopharynges of children in Kilifi District, Kenya. J Infect Dis. 2012;206:1020-9.

  3. Hernández S, García JJ, Gene A, Esteva C, del Amo E, Muñoz C. Pneumococcal carriage in children attending a hospital outpatient clinic in the era of pneumococcal conjugate vaccines in Barcelona. Diagnostic Microbiology and Infectious Disease. 2012;74:258-62.

  4. Pelton S, Weycker D, Farkouh R, Strutton D, Shea K, Edelsberg J. Risk of pneumococcal disease in children with chronic medical conditions in the era of pneumococcal conjugate vaccine. Clin Infect Dis. 2014;59(5):615-23.

  5. Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Hance LF, Reithinger R, et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoSMed [serie en Internet]. 2010 oct [citado 12 de Mayo de 2016];7. Disponible en: http://journals.plos.org/plosmedicine/article?id=10.1371%2Fjournal.pmed.1000348

  6. World Health Organization. Pneumococcal conjugate vaccine for childhood immunization: WHO position paper. Wkly Epidemiol Rec. 2007;82:93-104.

  7. Dickinson F, Rodríguez M, Toraño G. Pneumococcal meningitis in Cuban children and adolescents: A fifteen years follow up. Pediatrics Research International Journal [serie en Internet]. 2015 jun [citado 12 de Mayo de 2016]. Disponible en: http://www.ibimapublishing.com/journals/PRIJ/2015/596251/a596251.html

  8. Azevedo LCP, Toscano CM, Bierrenbach AL. Bacterial Meningitis in Brazil: Baseline Epidemiologic Assessment of the Decade Prior to the Introduction of Pneumococcal and Meningococcal Vaccines. PLoS ONE [serie en Internet]. 2013 jun [citado 12 de Mayo de 2016];8(6). Disponible en: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0064524

  9. Theodoridou MN, Vasilopoulou VA, Atsali EE, Pangalis AM, Mostrou GJ, Syriopoulou VP, et al. Meningitis registry of hospitalized cases in children: epidemiological patterns of acute bacterial meningitis throughout a 32-year period. BMC Infect Dis [serie en Internet]. 2007 [citado el 18 de Mayo de 2016];7. Disponible en: http://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-7-101

  10. Pérez AE, Dickinson FO, Rodríguez M. Community acquired bacterial meningitis in Cuba: a follow up of a decade. BMC Infectious Diseases. 2010;10(130):1-9.

  11. Granón Sl, Salvi Grabulosa MC, Requeira MM, Fossatti MS, von Specht MH. Pneumococcal meningitis in children under 15 years of age in Misiones (Argentina). Sixteen year's epidemiological surveillance. Rev Argent Microbiol. 2014;46(1):14-23.

  12. Maimaiti N, Lotfizadeh M, Ahmed Z, Rahimi A, Jadoo SA, Aljunid S. Incidence of pneumococcal meningitis in children less than 5 years age in Malaysia, Singapore and Thailand. Malaysian Journal of Public Health Medicine. 2015;15(1):25-9.

  13. Martínez E, Maciques R, González I, Moreno N, Rivera EG. Transplacental immunity to meningococcus B. Rev Cubana Pediatr. 1990;62(5):692-8.

  14. Obaro SK, Deubzer HE, Newman VO, Adegbola RA, Greenwood BM, Henderson DC. Serotype-specific pneumococcal antibodies in breast milk of Gambian women immunized with a pneumococcal polysaccharide vaccine during pregnancy. Pediatr Infect Dis J. 2004;23:1023-9.

  15. Assandri E, Amorín B, Gesuele JP, Algorta G, Pírez MC. Enfermedad neumocócica invasora en recién nacidos, antes y después de la vacunación universal con vacuna conjugada 7 y 13 valente en Uruguay. Rev Chilena Infectol. 2015;32(2):167-74.

  16. Hirose TE, Maluf EM, Rodrigues CO. Pneumococcal meningitis: epidemiological profile pre and post-introduction of the pneumococcal 10-valent conjugate vaccine. J Pediatr (Rio J). 2015;91(2):130-5.

  17. Ladhani SN, Andrews NJ, Waight P, Borrow R, Slack MP, Miller E. Impact of the 7- valent pneumococcal conjugate vaccine on invasive pneumococcal disease in infants younger than 90 days in England and Wales. Clin Infect Dis. 2013;56(5):633-40.

  18. Fernández B, Rubio L, Ruiz L, Cuadrado I, Kuder K. Streptococcus pneumoniae: The Forgotten Microorganism in Neonatal Sepsis. Fetal and Pediatric Pathology [serie en Internet]. 2015 jun [citado 12 de Mayo de 2016];34(3). Disponible en: http://www.clinica-santa-elena.org/resources/doc/150604-articulo-neumococo- 2931047940810966327.pdf

  19. Dickinson F, Pérez A, Galindo MA, Quintana I. Impacto de la vacunación contra Haemophilus influenzae tipo b en Cuba. Rev Panam Salud Pública. 2001;10(3):169-74.

  20. Sow SO, Tapia MD, Diallo S, Keita MM, Sylla M, Onwuchekwa U, et al. Haemophilus influenzae type b conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection. Am J Trop Med Hyg. 2009;80:1033-8.

  21. Domenech M, Damián D, Ardanuy C, Liñares J, Fenoll A, García E. Emerging, Non- PCV13 Serotypes 11A and 35B of Streptococcus pneumoniae Show High Potential for Biofilm Formation In Vitro. PLoS ONE [serie en Internet]. 2015 abr [citado 12 de Mayo de 2016];10(4). Disponible en: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0125636.

  22. Baldovin T, Lazzari R, Russo F, Bertoncello C, Buja A, Furlan P, et al. A surveillace system of invasive Pneumococcal Disease in North-Easter Italy. Ann Ig. 2015;27:15-24.

  23. Hussein AS, Shafran SD. Acute bacterial meningitis: a 12 year review. Medicine. 2000;79:360-8.

  24. Peltola V. Pneumococcal meningitis in the era of conjugate vaccines. Acta Paediatrica. 2010;99:1600-1.

  25. Camilli R, Daprai L, Cavrini F, Lombardo D, D'Ambrosio F, Del Grosso M, et al. Pneumococcal Carriage in Young Children One Year after Introduction of the 13-Valent Conjugate Vaccine in Italy. PLoS ONE [serie en Internet]. 2013 oct [citado 12 de Mayo de 2016];8(10). Disponible en: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0076309 .

  26. Dunais B, Bruno P, Touboul P, Degand N, Sakarovitch C, Fontas C. Impact of the 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage of Streptococcus pneumoniae Among Children Attending Group Daycare in Southeastern France. Pediatr Infect Dis J. 2015;34:286-8.

  27. Gessner BD, Mueller JE, Yaro S. African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults. BMC Infectious Diseases. 2010 Feb;10:22.

  28. Navarro-Torné A, Gomes Dias J, Hruba F, Lopalco PL, Pastore-Celentano L, Amato Gauci AJ, et al. Risk factors for death from invasive pneumococcal disease, Europe, 2010. Emerg Infect Dis [serie en Internet]. 2015 Mar [citado 12 de Mayo de 2016];21(3). Disponible en: http://wwwnc.cdc.gov/eid/article/21/3/14-0634_article

  29. Stockmann C, Ampofo K, Byington CL, Filloux F, Hersh Al, Blaschke AJ, et al. Pneumococcal Meningitis in Children: Epidemiology, Serotypes, and Outcomes From 1997-2010 in Utah. Pediatrics. 2013;132(3):421-8.

  30. Hui A, Ng K, Tong P, Mok V, Chow K, Wu A, et al. Bacterial meningitis in Hong Kong: 10-years' experience. Clin Neurol Neurosurg. 2005;107:366-70.

  31. Dotres CP, Puga R, Ricardo Y, Broño CR, Paredes B, Echemendía V, et al. Safety and preliminary immunogenicity of Cuban pneumococcal conjugate vaccine candidate in healthy children: A randomized phase I clinical trial. Vaccine. 2014;32:5266-70.




2020     |     www.medigraphic.com